EUVIMEDEUVIMED entdecken
Crossref

ROS-Responsive and Self-Catalytic Nanocarriers for a Combination of Chemotherapy and Reinforced Ferroptosis against Breast Cancer

Beibei Zhang iD, Hao Liu, Yifei Wang, Yong Zhang

ACS Biomaterials Science & Engineering · 2024

DOI: 10.1021/acsbiomaterials.4c01233 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, 2024. Verfasst von Beibei Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Magnetic Resonance Imaging, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450002, P. R. China. Hauptthemen laut MEDLINE: Ferroptosis, Breast Neoplasms, Reactive Oxygen Species, Paclitaxel. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Health Commission of Henan Province, National Natural Science Foundation of China, Medical Science and Technology Research Project of Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisBreast NeoplasmsReactive Oxygen SpeciesPaclitaxelDrug CarriersFerrous CompoundsHumansFemaleAnimalsNanoparticlesMetallocenesArtemisininsMiceCell Line, TumorAntineoplastic AgentsProdrugsHydrogen PeroxideMice, Inbred BALB CCatalysisMice, NudePolyethylene Glycols

Stichwörter der Autor:innen

Fenton reactionROS-responsivecancer therapyferroptosisnanoparticleself-catalytic

Substanzen

Reactive Oxygen SpeciesPaclitaxelDrug CarriersFerrous CompoundsMetallocenesferroceneartenimolArtemisininsAntineoplastic AgentsProdrugs

Autor:innen und Institutionen

  • Department of Magnetic Resonance Imaging, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450002, P. R. China.
  • Key Laboratory for Functional Magnetic Resonance Imaging and Molecular Imaging of Henan Province, Zhengzhou 450002, P. R. China.
  • Engineering Research Center of Medical Imaging Intelligent Diagnosis and Treatment of Henan Province, Zhengzhou 450002, P. R. China.

ORCID-Profile: Beibei Zhang

Förderung

  • Health Commission of Henan Province
  • National Natural Science Foundation of China
  • Medical Science and Technology Research Project of Henan Province

Zitieren

APA

Zhang, B., Liu, H., Wang, Y., & Zhang, Y. (2024). ROS-Responsive and Self-Catalytic Nanocarriers for a Combination of Chemotherapy and Reinforced Ferroptosis against Breast Cancer. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.4c01233

Vancouver

Zhang B, Liu H, Wang Y, Zhang Y. ROS-Responsive and Self-Catalytic Nanocarriers for a Combination of Chemotherapy and Reinforced Ferroptosis against Breast Cancer. ACS Biomaterials Science & Engineering. 2024. doi:10.1021/acsbiomaterials.4c01233

BibTeX
@article{Zhang2024,
  author = {Zhang, Beibei and Liu, Hao and Wang, Yifei and Zhang, Yong},
  title = {ROS-Responsive and Self-Catalytic Nanocarriers for a Combination of Chemotherapy and Reinforced Ferroptosis against Breast Cancer},
  journal = {ACS Biomaterials Science & Engineering},
  year = {2024},
  doi = {10.1021/acsbiomaterials.4c01233}
}
Kostenlos starten →